Dr. Franz Kerek founder, CEO

Franz has a solid background in natural product chemistry with more than 25 years of experience in academic research in Romania, at the Ruhr University Bochum and with Max Planck Institute for Biochemistry in Munich. Disclosing the natural pain reliever substance DON-168 marks a breakthrough scientific discovery with broad application potential. The recent identification of the natural biologically active oligo-silicic acid SOSA and its presumptive role in the regulation of some membrane transporter enzymes provides the basis of the here presented drug development projects. Franz founded and successfully manages two spin-off biotech companies in the Innovation Centre IZB in Munich. He published up to 80 per-reviewed scientific papers relating the structure, chemistry and pharmacology of novel natural substances and has patents for their healthcare application.